← Open Payments lookup

NINA FONTENEAUX: Open Payments

NPI 1407390693 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$965 in 44 payments from 10 companies in 2025. Trend: 2023 $434 · 2024 $875 · 2025 $965

Food & beverage: $965
CompanyPaymentsAmount
Madrigal Pharmaceuticals24$583
Phathom Pharmaceuticals, Inc.7$109
ABBVIE INC.3$58
Takeda Pharmaceuticals U.S.A., Inc.2$58
Ardelyx, Inc.2$36
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$34
Mallinckrodt Hospital Products Inc.1$26
Aimmune Therapeutics, Inc.1$23
EVOKE PHARMA, INC.1$20
Novo Nordisk Inc1$19

Products named: REZDIFFRA, VOQUEZNA, ENTYVIO, CREON, IBSRELA, XIFAXAN, TERLIVAZ, ZENPEP.

Industry payments across TX — which companies pay providers there.